Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Research And Development Expense of $2.65 million for the year ending 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +14.8% in Research And Development Expense from 2024 to 2025.
- This data is from Harvard Apparatus Regenerative Technology, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $1.06 million | Q1 2013: $1.16 million | Q2 2013: $1.27 million | Q3 2013: $1.06 million | Q1 2014: $1.22 million | Q2 2014: $1.21 million | Q3 2014: $1.40 million | Q1 2015: $1.24 million | Q2 2015: $1.05 million | Q3 2015: $1.27 million | Q1 2016: $1.38 million | Q2 2016: $1.68 million | Q3 2016: $2.23 million | Q1 2017: $2.07 million | Q2 2017: $2.69 million | Q3 2017: $2.36 million | Q1 2018: $552.0 thousand | Q2 2018: $928.0 thousand | Q3 2018: $1.29 million | Q1 2019: $1.03 million | Q2 2019: $1.38 million | Q3 2019: $1.60 million | Q1 2020: $643.0 thousand | Q2 2020: $536.0 thousand | Q3 2020: $548.0 thousand | Q1 2021: $473.0 thousand | Q2 2021: $300.0 thousand | Q3 2021: $250.0 thousand | Q1 2022: $303.0 thousand | Q2 2022: $326.0 thousand | Q3 2022: $369.0 thousand | Q1 2023: $509.0 thousand | Q2 2023: $1.57 million | Q3 2023: $339.0 thousand | Q1 2024: $840.0 thousand | Q2 2024: $642.0 thousand | Q3 2024: $557.0 thousand | Q1 2025: $601.0 thousand | Q2 2025: $697.0 thousand | Q3 2025: $655.0 thousand.
- Over the full 14 years of available data (2012 to 2025), Harvard Apparatus Regenerative Technology, Inc.'s Research And Development Expense has declined by 34.1%.
- Historical annual values: Fiscal year 2025: $2.65 million | Fiscal year 2024: $2.31 million | Fiscal year 2023: $3.06 million | Fiscal year 2022: $1.74 million | Fiscal year 2021: $1.59 million | Fiscal year 2020: $2.07 million | Fiscal year 2019: $4.85 million | Fiscal year 2018: $3.92 million | Fiscal year 2017: $7.59 million | Fiscal year 2016: $7.60 million | Fiscal year 2015: $4.79 million | Fiscal year 2014: $5.12 million | Fiscal year 2013: $4.56 million | Fiscal year 2012: $4.03 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: